Covax opens new front in pandemic arms race for world's poorest countries
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SUNDAY, MAY 29, 2022
SUNDAY, MAY 29, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Covax opens new front in pandemic arms race for world's poorest countries

Coronavirus chronicle

BSS/AFP
23 January, 2022, 01:15 pm
Last modified: 23 January, 2022, 02:00 pm

Related News

  • PM for concluding global treaty to face future pandemics
  • Covax calls for urgent action to close vaccine equity gap
  • Covax calls for urgent action to close vaccine equity gap
  • Govt bans low priority foreign tours for more organisations
  • Kamal thanks ADB for budget aid during pandemic

Covax opens new front in pandemic arms race for world's poorest countries

The top Covax donor-funded dose recipients so far are Bangladesh with 130 million, Indonesia 87 million, Pakistan 77 million and the Philippines 66 million

BSS/AFP
23 January, 2022, 01:15 pm
Last modified: 23 January, 2022, 02:00 pm
Photo: BSS/AFP
Photo: BSS/AFP

Covax aims to break the Covid-19 pandemic in 2022 by ensuring a steady supply of vaccines at last for the world's poorest countries -- and swiftly getting them into arms.

The global scheme, aimed at procuring donor-funded jabs for the 91 weakest economies, delivered its one billionth dose last weekend -- a major milestone that came far later than anticipated after a year of setbacks.

The battle for Covax in 2021 was getting hold of doses -- besides rich countries cornering most of the vaccine supply, it faced export bans from producer countries, regulatory red tape and manufacturing delays.

Rather than bulk-bought jabs, the scheme ended up relying on doses donated by wealthy nations, which too often were about to expire and couldn't be used in time.

Covax sees the new front in 2022 as smoothing the supply chain -- from a reliable stream off the production lines to efficient distribution set-ups in recipient countries.

The facility is co-led by the World Health Organization (WHO); the Gavi vaccine alliance, which handles procurement; and CEPI, the Coalition for Epidemic Preparedness Innovations, which invests in prospective vaccines.

- 'Inequity 2.0' fear -

Covax this week called for $5.2 billion over the next three months to steady the ship this year.

"We can break the cycle of transmission and the pain and suffering," Gavi chief Seth Berkley told the funding drive launch.

However, "what we do not have today are the resources to help countries adapt to the new challenges that we know Covid-19 will create in 2022".

Covax therefore wants to build a pool of 600 million doses to ensure a reliable supply, and to cover eventual variables such as boosters or new variant-specific vaccines.

It also needs to support readiness and delivery in poorer nations, and cover the costs of syringes and transportation.

"I think we'll still have rocky supply for the next six months or so and I'm a little worried, frankly, if there are new variant vaccines, that we might have an inequity 2.0," said Berkley.

Covax reckons it has enough confirmed vaccine supplies to jab 45 percent of the population in the poorest 91 economies.

But the WHO wants 70 percent fully jabbed in every country by July to end the acute phase of the pandemic -- a much bigger stretch, given how far behind many countries are, especially in Africa, where more than 85 percent of people are yet to receive a single dose.

At the current pace of vaccine roll-out, 109 countries will miss the mid-2022 target, the WHO has said.

- 'Back on track' -

Covax was launched in June 2020, when few would have imagined that several highly effective vaccines would emerge within nine months. Historically, the vast majority of potential vaccines fail.

The first Covax doses were administered in March 2021, "but then we hit barrier after barrier", said Berkley.

"We were able to get this back on track -- and now you're seeing an accelerated drive towards getting vaccines out."

The next billion doses is expected to take four to five months to deliver.

Of the billion doses delivered so far, around 285 million were AstraZeneca, 260 million Pfizer, 150 million Moderna, 125 million Janssen, 95 million Sinopharm and 85 million Sinovac.

Only WHO-approved vaccines can be used, of which there are eight so far. The latest is a major CEPI-funded vaccine, Novavax, which could do much of the heavy lifting in 2022.

- Jabs for all 'achievable' -

CEPI chief executive Richard Hatchett said the target was now building capacity in poorer countries to roll out mass vaccination at speed.

"The last mile is going to be the major challenge for 2022," he told a World Economic Forum session.

Up to 25 countries need particular help getting their vaccination programme in shape.

Overall, some 9.8 billion Covid-19 vaccine doses have been administered around the world. Covax jabs account for 82 percent of injections in the 91 poorest economies.

The top Covax donor-funded dose recipients so far are Bangladesh with 130 million, Indonesia 87 million, Pakistan 77 million and the Philippines 66 million.

Hatchett said that with the manufacturing capacity now available, helping poorer countries turn those doses into vaccinations could transform the course of the pandemic.

Whether primary vaccination or a booster, getting a jab to everyone who wants one "is an achievable goal in 2022", he insisted.

Top News / World+Biz

COVAX / pandemic

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Finance projects export fall, remittance rise
    Finance projects export fall, remittance rise
  • Photo: Reuters
    Vinicius, Courtois help Real edge out Liverpool for 14th European crown
  • Women voluntarily joined the peaceful procession and protested by wearing clothing of their own choice. Photo: Trishia Nashtaran
    The unhealthy obsession with what women wear

MOST VIEWED

  • Photo: Collected
    US doctors reconsider Pfizer's Paxlovid for lower-risk Covid patients
  • People wearing protective face masks walk on a street, following new cases of the coronavirus disease (Covid-19), in Shanghai, China August 25, 2021. REUTERS/Aly Song
    'Tomorrow will be better': Shanghai inches towards Covid re-opening
  • North Korea says new fever cases under 100,000 as virus fight heats up
    North Korea says new fever cases under 100,000 as virus fight heats up
  • People in protective suits cross a street during lockdown, amid the coronavirus disease (COVID-19) pandemic, in Shanghai, China, May 26, 2022. REUTERS/Aly Song
    Shanghai heading out of lockdown but China still lost in economic gloom
  • A woman wearing a face mask crosses a road at the Central Business District (CBD), amid the coronavirus disease (Covid-19) outbreak in Beijing, China May 10, 2022. REUTERS/Carlos Garcia Rawlins
    Tightening Covid net, Beijing deals out punishments, stark warnings
  • A medical worker takes a swab sample from a person for a nucleic acid test at a makeshift testing site, amid the coronavirus disease (Covid-19) outbreak, in Beijing, China May 23, 2022. REUTERS/Tingshu Wang
    Beijing ramps up Covid quarantine, Shanghai residents decry uneven rules

Related News

  • PM for concluding global treaty to face future pandemics
  • Covax calls for urgent action to close vaccine equity gap
  • Covax calls for urgent action to close vaccine equity gap
  • Govt bans low priority foreign tours for more organisations
  • Kamal thanks ADB for budget aid during pandemic

Features

Women voluntarily joined the peaceful procession and protested by wearing clothing of their own choice. Photo: Trishia Nashtaran

The unhealthy obsession with what women wear

7h | Panorama
Illustration: Freepik

Bangladesh is on the verge of destigmatising menstruation

12h | Features
Photo: Collected

The death of Davos?

18h | Panorama
A male Baya Weaver beating wings. Photo: Enam Ul Haque

Baya Weavers weave: ‘Must be witnessed to be fully credited’

21h | Panorama

More Videos from TBS

Attorney General's suggestion to reduce case clutter

Attorney General's suggestion to reduce case clutter

12h | Videos
Russian forces take Liman city of Ukraine

Russian forces take Liman city of Ukraine

12h | Videos
JU food prices spike, students suffer

JU food prices spike, students suffer

12h | Videos
5% tax on poultry farmers earning above Tk10 lakh

5% tax on poultry farmers earning above Tk10 lakh

12h | Videos

Most Read

1
Bangladesh Bank GM, DGM’s designation changed
Banking

Bangladesh Bank GM, DGM’s designation changed

2
Corporates go cashless…tax cut on cards
NBR

Corporates go cashless…tax cut on cards

3
Photo: Courtesy
Panorama

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

4
British International Investment (BII) CEO Nick O’Donohoe. Illustration: TBS
Economy

BII to invest $450m in Bangladesh in 5 years

5
Representational image. Picture: Pixabay
Economy

Govt raises regulatory duty to discourage imports of 130 products

6
Photo: Collected
Industry

Spanish recycled cotton producer opens new facility in Bangladesh

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab